| Dr Mark A Sharzer, MD | |
|
3033 W Orange Ave, Anaheim, CA 92804-3156 | |
| (174) 229-4060 | |
| Not Available |
| Full Name | Dr Mark A Sharzer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 43 Years |
| Location | 3033 W Orange Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053426247 | NPI | - | NPPES |
| 00G496410 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G49641 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garden Grove Hospital & Medical Center | Garden grove, CA | Hospital |
| West Anaheim Medical Center | Anaheim, CA | Hospital |
| La Palma Intercommunity Hospital | La palma, CA | Hospital |
| Huntington Beach Hospital | Huntington beach, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John P Anderson Md Russell M Perry Md And Mark A Sharzer Md A Med Crp | 5496774580 | 6 |
News Archive
Child development experts have long known that children with attention-deficit hyperactivity disorder are more likely to have an accident while crossing the street on their bicycles.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
The ACP strongly supports the intent of the proposed rule, and believes that an ACO model has the potential of supporting such important care delivery goals as enhancing quality, efficiency, integration, and patient-centeredness.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 3 days ago
| Entity Name | John P Anderson Md Russell M Perry Md And Mark A Sharzer Md A Med Crp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467567511 PECOS PAC ID: 5496774580 Enrollment ID: O20051117000698 |
News Archive
Child development experts have long known that children with attention-deficit hyperactivity disorder are more likely to have an accident while crossing the street on their bicycles.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
The ACP strongly supports the intent of the proposed rule, and believes that an ACO model has the potential of supporting such important care delivery goals as enhancing quality, efficiency, integration, and patient-centeredness.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 3 days ago
| Entity Name | N Rahbar Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619030921 PECOS PAC ID: 8921102351 Enrollment ID: O20070324000071 |
News Archive
Child development experts have long known that children with attention-deficit hyperactivity disorder are more likely to have an accident while crossing the street on their bicycles.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
The ACP strongly supports the intent of the proposed rule, and believes that an ACO model has the potential of supporting such important care delivery goals as enhancing quality, efficiency, integration, and patient-centeredness.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Sharzer, MD Po Box 646, Stanton, CA 90680-0646 Ph: (562) 809-3568 | Dr Mark A Sharzer, MD 3033 W Orange Ave, Anaheim, CA 92804-3156 Ph: (174) 229-4060 |
News Archive
Child development experts have long known that children with attention-deficit hyperactivity disorder are more likely to have an accident while crossing the street on their bicycles.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
The ACP strongly supports the intent of the proposed rule, and believes that an ACO model has the potential of supporting such important care delivery goals as enhancing quality, efficiency, integration, and patient-centeredness.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 3 days ago
Jay Kang, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4611 Fax: 714-279-5524 | |
Dr. Andrew J Hwang, M. D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3440 E La Palma Ave, Amc Department Of Radiology, Anaheim, CA 92806 Phone: 714-644-2000 | |
Dr. John Charles Kirby, D.O. Radiology Medicare: May Accept Medicare Assignments Practice Location: 5528 E La Palma Ave, Suite 4-a, Anaheim, CA 92807 Phone: 714-970-0200 Fax: 714-970-0270 | |
Anthony G. Caldarone, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Alfonso N. Pham, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dr. Tan Ba Nguyen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5528 E La Palma Ave Ste 4a, Anaheim, CA 92807 Phone: 714-970-0200 |